Vaccine Delivery Devices Market Based on Device (Syringes, Jet Injectors, Other), Based on Route of Administration(Intradermal Vaccination, Intramuscular Vaccination, Other), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2023-2032

Report Overview

Vaccine Delivery Devices Market size is expected to be worth around USD 10.7 Bn by 2032 from USD 5.4 Bn in 2022, growing at a CAGR of 7.3% during the forecast period from 2023 to 2032.

A key element in the prevention and management of infectious diseases is vaccination. The availability of suitable vaccine delivery methods and vaccines is essential for effective vaccine administration. Devices for administering vaccinations are made to do so to their intended target safely and effectively. Some of the major drivers influencing the market's expansion include expanding vaccine programs and their expanding coverage, expanding research in the field of vaccination, increased government support and investment, the discovery of innovative vaccines, and numerous campaigns and initiatives.

Governments worldwide are collaborating with biotech and pharmaceutical businesses to establish a strategy to address supply chain issues with vaccine delivery. In addition, the need for an immediate COVID-19 vaccination has sparked interest in developing a safe and efficient viral delivery mechanism or, ideally, several delivery systems.

Driving factors

The Rise of New Illnesses, The Expansion of Vaccination Programs Across the World

The rise of new illnesses and the expansion of vaccination programs worldwide. The growing demand for effective medication delivery methods and other factors contribute to the growth of the global market for vaccine delivery devices.

To stop the spread of infectious illnesses, governments, and healthcare organizations worldwide are making significant investments in vaccination programs, particularly in developing nations. The need for vaccine delivery tools such as syringes, needles as well as injectors has increased. The market for vaccine delivery is driven by the increasing demand for secure as well as effective drug delivery methods. Vaccines are sensitive products that must also be handled and administrated correctly in order to be effective. Such as patients and healthcare professionals are becoming more and more interested in vaccination delivery systems that provide precise doses, reduce pain as well as increase safety.

The adoption of self-administration devices and technological advances are two main factors driving the global market for vaccine delivery device market. The delivery of vaccines has been transformed by the creation of new technologies, such as wearable injectors as well patch pumps, which have improved patient accessibility and convenience. This device has benefits such as enhanced adherence, less discomfort, also increased patient comfort, which improves patient outcomes.

Restraining Factors

The lack of good infrastructure in any country or region of the world is one of the barriers to the widespread use of vaccination delivery systems. This infrastructure consists of the necessary transportation and storage facilities as well as qualified medical personnel who can safely and effectively administer the vaccine. Unfortunately, electricity, refrigeration, and other resources necessary to preserve the quality of vaccinations during storage and transit are not always readily available in some places. Additionally, particularly in distant or impoverished areas, there may be a dearth of qualified healthcare professionals who can deliver vaccines.

The price of these devices is another barrier to widespread vaccine distribution. Many low- and middle-income nations might not have the money to invest in pricey vaccination distribution systems, especially if they also need to spend money on other healthcare infrastructure projects like building clinics, hospitals, and medical equipment. Additionally, even if the devices are inexpensive, the continuous expenses of upkeep, repair, and replacement may be too high for many nations. As a result, there may be vaccines available but ineffectively administered due to a dearth of suitable delivery methods.

By Device Analysis

The Syringes Segment Accounted for the Largest Revenue Share in Vaccine Delivery Device Market in 2022.

Based on devices, syringes dominate the vaccine delivery device market with an 83% market share. Syringes are becoming more common since they lower the risk of contamination or dose mistakes. In order to protect patients and lower the danger of needle stick injuries, auto-disable syringes are made to only be used once. Retractable needles or shields are features of safety syringes that guard against unintentional needle stick injuries. The most widely used syringes for administering vaccines are conventional ones, which come in a variety of sizes. The growing demand for vaccinations as well as the requirement for effective vaccine-delivery devices are likely to fuel the growth of the global market for vaccine-delivery devices. Because of their convenience and safety characteristics, prefilled and safe syringes are becoming more and more popular.

By Route of Administration Analysis

The Intradermal Segment Holds the Significant Share of the Format Segment in the Vaccine Delivery Device Market.

Based on the route of administration, the intradermal segment dominates the global vaccine delivery device market with a 61% market share. Due to advantages including dose sparing, increased safety, and easier access to vaccines, this vaccine delivery method has gained attention in recent years. Over the ensuing years, these aspects are anticipated to aid in this segment's expansion. In addition, the segment is also expected to be driven by a rise in research on alternate techniques for intradermal administration using cutting-edge tools like jet injectors and microneedles.

Intramuscular is Identified as Fastest Growing Segment in Projected Period.

Intramuscular vaccination is projected to be the fastest-growing segment due to the intramuscular method used to administer most vaccinations. This method of delivery lessens side effects at the injection site. Intramuscular injections are commonly used because they deliver drugs deeply inside muscle tissues and cause rapid absorption.

Key Market Segments

Based on Device

• Syringes
• Jet Injectors
• Other

Based on Route of Administration

• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other

Growth Opportunity

The Growing Demand for Vaccines Globally Is One of the Main Factors Causing This Development.

The market for vaccine delivery systems has been expanding consistently over the past several years and it is anticipated to do in the years to come. The growing demand for vaccines globally is one of the main factors causing this development. Worldwide distribution of vaccines is urgently required because of the current COVID-19 epidemic.

As a result, there is now significantly more need for vaccination administration tools such as syringes, needles, and jet injectors. The development of vaccine delivery systems through technology is also boosting the industry. For instance, the creation of microneedle patches for the delivery of vaccinations is a promising new technique that enables quick and painless vaccination. This technology has the potential to revolutionize vaccine administration and raise vaccination rates all around the world.

The growing emphasis on patient safety and the lowering of medical errors presents another potential opportunity in the market for vaccine delivery devices. Due to its capacity to lower the risk of needle stick injuries and the spread of infectious diseases, the usage of needle-free injection systems and safety-engineered devices is growing in popularity. Furthermore, the usage of smart devices is growing, including connected syringes and auto-injectors that enable precise dosing and real-time monitoring of vaccine administration.

Latest Trends

Development of Innovative Technologies and Devices to Deliver Vaccines Efficiently and Effectively.

In order to deliver the vaccine to the dermis which contains a lot of immune cells, micro needled are tiny needles that can penetrate the skin. The vaccine is administrated directly to the immune cell using this method, which is painless and more effective than a conventional needle injection. By removing the requirement for trained medical professionals to administer vaccines, microneedles also increase the accessibility and financial viability of immunization programmers. Microneedles are also perfect for use in underdeveloped nations and distant locations because they have a longer shelf life and don't need refrigeration.

The creation of wearable vaccine patches is another breakthrough in the market for vaccine delivery systems. These skin-wearable patches deliver the vaccine via tiny needles or an adhesive that has been coated with medication. Wearable immunization patches are a painless, non-invasive alternative to standard injections using needles. They can also be self-administered, which is helpful for patients who prefer to avoid medical facilities or find it difficult to get to them.

Wearable vaccine delivery systems have many benefits over more conventional vaccine delivery techniques. They are more effective than typical needle injections because they use less vaccination to elicit the same immune response. Due to their reduced danger of needle-stick injuries and lack of requirement for skilled medical workers, they are also more cost-effective.

Wearable vaccine patches are also suited for usage in underdeveloped nations and distant locations because they have a longer shelf life and don't need refrigeration. Overall, because they provide a secure, efficient, and practical manner of administering vaccines, wearable vaccine patches represent a significant advancement in the market for vaccine delivery devices.

Regional Analysis

North America Accounted for the Largest Revenue Share in Vaccine Delivery Device Market in 2022.

North America is estimated to be the most lucrative market in the vaccine delivery device market, with the largest market share of 30%. Due to the high frequency of infectious illnesses growing government initiatives for immunization programs and the presence of large market participants. North America is a key market for the vaccine delivery device. The biggest market in this area is the united states, followed by Canada. The market is expanding with the growing use of cutting-edge vaccine delivery devices such as needle-free injectors, jet injectors, and microneedles.

Middle East and Africa is Expected as Fastest Growing Region in Projected Period in Vaccine Delivery Device Market

Middle East and Africa is expected as fastest growing region in the forecast period in the vaccine delivery device market. with expanding government initiatives to increase vaccination coverage and the burden of infectious illnesses, the Middle East and Africa are emerging markets for vaccine delivery systems. The main market in this region is South Africa, Saudi Arabia, and the United Arab Emirates The adoption of cutting-edge vaccination delivery technologies and rising infrastructure spending in the healthcare industry are propelling market expansion.

Key Regions and Countries

North America

• US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Key Players Analysis

Information about each rival is provided in the competitive environment for vaccine administration devices. The report contains details on the company's financial health, revenue generated, market potential, R&D investments, global presence, production sites, new market initiatives, and facilities, production capacities, product launch, company strengths and weaknesses, product breadth and depth, and application dominance. Only the market for vaccine administration devices is covered in the information above.

Top Key Players in the Vaccine Delivery Devices Market

• Becton Dickinson & Company
• Bioject Medical Technologies Inc
• PharmaJet
• Vaxxas
• Gerresheimer AG
• SCHOTT AG
• Corium International Inc
• 3M
• Other

Recent Development

• In June 2021, PharmaJet began accepting participants for a needle-free COVID-19 immunization study
• In November 2020, Mylan NV changed its name to Viatris becoming the worldwide pharmaceutical company created by the union of Mylan and the Upjohn division of Pfizer Inc.

Report Scope